U.S. Tobacco Stock News

Recent share performance and business profile Global Payments (GPN) has been on many investors’ radar after a period of weaker share performance, with the stock down over the past year and the past 3 months. The company processes card, check, and digital-based payments and reports through two main segments: Merchant Solutions and Issuer Solutions, across the Americas, Europe, and the Asia-Pacific. See our latest analysis for Global Payments. At a share price of US$68.48, Global Payments has...

Event context and recent stock performance Ligand Pharmaceuticals (LGND) has come into focus after a period in which its shares have moved lower over the past month and past 3 months, while still showing a positive 1 year total return. At a last close of US$183.83, the company carries a value score of 3, with annual revenue of US$251.233 million and net income of US$48.581 million, supported by positive annual revenue and net income growth. See our latest analysis for Ligand...

Ball Corporation ( NYSE:BALL ) has announced that it will pay a dividend of $0.20 per share on the 16th of March. The...

Flutter Entertainment (FLUT) is in focus after several major brokers recently cut their expectations, highlighting concerns about softer growth in US online sports betting and the potential for higher share volatility ahead of upcoming quarterly results. See our latest analysis for Flutter Entertainment. The recent reset in broker expectations has come alongside a sharp swing in sentiment, with Flutter’s share price at US$125.17 after a 1 month share price return decline of 33.58%. This has...

Atmus Filtration Technologies (ATMU) has capped FY 2025 with Q4 revenue of US$446.6 million and basic EPS of US$0.59. Trailing twelve month revenue landed at US$1.76 billion with EPS of US$2.52 and net income of US$207.4 million. The company has seen quarterly revenue move from US$403.7 million and EPS of US$0.53 in Q3 2024 to the current Q4 2025 levels. Trailing twelve month EPS has stepped up from US$2.16 to US$2.52 over the same comparison points, setting up a results season where...

Appian Corporation recently presented at the WEST Conference 2026 at the San Diego Convention Center, sharing updates with defense and technology stakeholders about its low-code and automation capabilities. This appearance gives investors a fresh window into how Appian is positioning its platform for complex, regulated use cases that often demand robust workflow automation. Next, we’ll examine how Appian’s WEST Conference 2026 presentation might influence its investment narrative,...

Tesla (TSLA) is under pressure after January vehicle sales dropped 45% in China and 17% in the US, while it surrendered the top electric vehicle spot in Europe and increased spending on AI, robotics, and energy projects. See our latest analysis for Tesla. Against this backdrop of weaker vehicle demand and heavier spending on AI and robotics, Tesla’s share price has been choppy, with a 30 day share price return of a 4.59% decline, a 1 year total shareholder return of 17.31%, and a 3 year total...

IPG Photonics (NasdaqGS:IPGP) has introduced the CROSSBOW MINI High-Energy Laser system, a new scalable defense product aimed at countering drone threats. The company reports strong momentum in its medical business, supported by new product launches and a major customer win. Management has indicated that medical-related revenues are expected to double or triple in the next year. IPG Photonics, trading at about $153.91, has seen very strong recent share price performance, with the stock up...

Why Truist Financial is on investors’ radar Truist Financial (TFC) is back in focus after recent trading left the shares with a mixed return profile, including a small 1 day pullback but gains over the month and past 3 months. See our latest analysis for Truist Financial. While the 1 day share price return of a 0.33% decline to US$51.90 and the 7 day share price return of a 7.01% decline hint at some cooling after recent strength, the 30 day and 90 day share price returns of 3.82% and 18.17%...

In recent days, TJX Companies has drawn renewed attention as multiple Wall Street firms reiterated positive ratings, short interest eased, and investors looked ahead to the company’s upcoming fourth-quarter and full-year Fiscal 2026 earnings release and conference call held on February 25, 2026. Together with favorable earnings estimate revisions and a strong ranking from Zacks, these developments point to improving sentiment around TJX’s off-price retail model as it prepares to update the...

The board of Koppers Holdings Inc. ( NYSE:KOP ) has announced that the dividend on 23rd of March will be increased to...

Shareholders might have noticed that Mastercard Incorporated ( NYSE:MA ) filed its annual result this time last week...

Gold.com, Inc. ( NYSE:GOLD ) stock is about to trade ex-dividend in four days. The ex-dividend date is one business day...

As you might know, Sensus Healthcare, Inc. ( NASDAQ:SRTS ) last week released its latest annual, and things did not...

To the annoyance of some shareholders, Sabre Corporation ( NASDAQ:SABR ) shares are down a considerable 26% in the last...

The Creative Global Technology Holdings Limited ( NASDAQ:CGTL ) share price has softened a substantial 39% over the...

Alliance Entertainment Holding Corporation ( NASDAQ:AENT ) shares have had a horrible month, losing 29% after a...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

1-800-FLOWERS.COM, Inc. ( NASDAQ:FLWS ) shares have retraced a considerable 25% in the last month, reversing a fair...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Elutia Inc. ( NASDAQ:ELUT ) shares have continued their recent momentum with a 28% gain in the last month alone. But...

The recent price decline of 15% in Cosmos Health Inc.'s ( NASDAQ:COSM ) stock may have disappointed insiders who bought...

To the annoyance of some shareholders, Cosmos Health Inc. ( NASDAQ:COSM ) shares are down a considerable 27% in the...

Investors may wish to note that the CEO, President & Director of Sagimet Biosciences Inc. , David Happel, recently...